Integra LifeSciences Holdings is a global medical technology company that specializes in developing and manufacturing innovative solutions for neurosurgery, orthopedic surgery, and regenerative medicine. Their products and technologies aim to improve patient outcomes and enhance surgical procedures in various medical specialties. Integra LifeSciences is committed to advancing medical science and providing healthcare professionals with the tools they need to deliver high-quality patient care.

The stock of Integra LifeSciences Holdings is currently characterized as messy, with prices trading near multi-year lows. This indicates a period of significant decline and potential oversold conditions in the stock. 

Traders and investors should exercise caution and closely monitor key technical indicators, such as support levels and price patterns, to assess the stock's potential for a reversal or consolidation. Due to the messy nature of the stock's price action and its proximity to multi-year lows, it is advisable to wait for clearer signals or a potential turnaround before considering any significant trading or investment decisions.